|
Volumn 12, Issue 6, 2013, Pages 644-647
|
Cell therapy companies make strong progress from October 2012 to March 2013 amid mixed stock market sentiment
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ARTICLE;
BIOTECHNOLOGY;
CELL THERAPY;
DRUG INDUSTRY;
EMBRYONIC STEM CELL;
HEALTH CARE COST;
HUMAN;
PRIORITY JOURNAL;
COMPARATIVE STUDY;
ECONOMICS;
INVESTMENT;
STEM CELL RESEARCH;
STEM CELL TRANSPLANTATION;
HUMANS;
INVESTMENTS;
STEM CELL RESEARCH;
STEM CELL TRANSPLANTATION;
|
EID: 84878836586
PISSN: 19345909
EISSN: 18759777
Source Type: Journal
DOI: 10.1016/j.stem.2013.05.017 Document Type: Note |
Times cited : (15)
|
References (9)
|